Gilead Sciences
GILD
#80
Rank
NZ$380.70 B
Marketcap
NZ$306.94
Share price
-0.75%
Change (1 day)
36.58%
Change (1 year)

Earnings for Gilead Sciences (GILD)

Earnings in 2026 (TTM): -NZ$4.57 Billion

According to Gilead Sciences's latest financial reports the company's current earnings are NZ$30.98 Billion. In 2025 the company made an earning of NZ$17.79 Billion, an increase over its 2024 earnings that were of NZ$1.25 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Gilead Sciences from 1991 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$4.57 Billion-125.63%
2025 NZ$17.79 B1319.86%
2024 NZ$1.25 B-89.94%
2023 NZ$12.45 B17.97%
2022 NZ$10.56 B-29.77%
2021 NZ$15.03 B395.99%
2020 NZ$3.03 B-67.66%
2019 NZ$9.37 B-33.84%
2018 NZ$14.16 B-42.35%
2017 NZ$24.57 B-20.87%
2016 NZ$31.05 B-21.06%
2015 NZ$39.34 B45.8%
2014 NZ$26.98 B253.01%
2013 NZ$7.64 B16.51%
2012 NZ$6.56 B-1.07%
2011 NZ$6.63 B-6.71%
2010 NZ$7.10 B11.75%
2009 NZ$6.36 B29.5%
2008 NZ$4.91 B19.11%
2007 NZ$4.12 B-455.74%
2006 -NZ$1.16 Billion-154.93%
2005 NZ$2.11 B76.99%
2004 NZ$1.19 B-266.16%
2003 -NZ$0.72 Billion-638.24%
2002 NZ$0.13 B31.5%
2001 NZ$0.10 B-242.15%
2000 -NZ$71.33 Million-40.2%
1999 -NZ$0.12 Billion31.85%
1998 -NZ$90.46 Million8.73%
1997 -NZ$83.2 Million27.22%
1996 -NZ$65.4 Million
1994 -NZ$62.31 Million26.57%
1993 -NZ$49.23 Million46.49%
1992 -NZ$33.61 Million362.5%
1991 -NZ$7.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$34.00 B-839.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.65 B-375.09%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$23.27 B-605.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.15 B-1,472.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.07 B-536.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
NZ$0.80 B-117.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
NZ$2.02 B-144.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$8.28 B-280.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.21 B-365.42%๐Ÿ‡บ๐Ÿ‡ธ USA